These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
177 related items for PubMed ID: 34824046
1. Overview of drug treatment for paroxysmal supraventricular tachycardia in Taiwan emergency departments: Adenosine using trend from 2000 to 2012. Li YH, Hung SC, Hung HC, Chan KC, Li YC, Liu LL, Chao WY, Huang JW, Hsu HW. Australas Emerg Care; 2022 Sep; 25(3):224-228. PubMed ID: 34824046 [Abstract] [Full Text] [Related]
2. Adenosine for the prehospital treatment of paroxysmal supraventricular tachycardia. Gausche M, Persse DE, Sugarman T, Shea SR, Palmer GL, Lewis RJ, Brueske PJ, Mahadevan S, Melio FR, Kuwate JH. Ann Emerg Med; 1994 Aug; 24(2):183-9. PubMed ID: 8037382 [Abstract] [Full Text] [Related]
4. Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group. DiMarco JP, Miles W, Akhtar M, Milstein S, Sharma AD, Platia E, McGovern B, Scheinman MM, Govier WC. Ann Intern Med; 1990 Jul 15; 113(2):104-10. PubMed ID: 2193560 [Abstract] [Full Text] [Related]
8. Heart rate is a predictor of success in the treatment of adults with symptomatic paroxysmal supraventricular tachycardia. Ballo P, Bernabò D, Faraguti SA. Eur Heart J; 2004 Aug 15; 25(15):1310-7. PubMed ID: 15288158 [Abstract] [Full Text] [Related]
13. Rationale and design of the NODE-303 study: evaluating the safety of symptom-prompted, self-administered etripamil for paroxysmal supraventricular tachycardia episodes in real-world settings. Ip JE, Bui H, Camm AJ, Coutu B, Noseworthy PA, Parody ML, Sears SF, Singh N, Uribe JA, Vyselaar J, Omodele S, Shardonofsky S, Bharucha DB, Stambler B. Am Heart J; 2024 Apr 15; 270():55-61. PubMed ID: 38266665 [Abstract] [Full Text] [Related]
14. Efficacy of intravenous adenosine in treatment of paroxysmal supraventricular tachycardia in the local population. Seet CM. Singapore Med J; 1997 Dec 15; 38(12):525-8. PubMed ID: 9550919 [Abstract] [Full Text] [Related]
15. Conversion rates for prehospital paroxysmal supraventricular tachycardia (PSVT) with the addition of adenosine: a before-and-after trial. Morrison LJ, Allan R, Vermeulen M, Dong SL, McCallum AL. Prehosp Emerg Care; 2001 Dec 15; 5(4):353-9. PubMed ID: 11642584 [Abstract] [Full Text] [Related]
16. Adenosine for paroxysmal supraventricular tachycardia. DiPalma JR. Am Fam Physician; 1991 Sep 15; 44(3):929-31. PubMed ID: 1877434 [Abstract] [Full Text] [Related]
17. Association of Paroxysmal Supraventricular Tachycardia with Ischemic Stroke: A National Case-Control Study. Chiang JK, Kao HH, Kao YH. J Stroke Cerebrovasc Dis; 2017 Jul 15; 26(7):1493-1499. PubMed ID: 28366662 [Abstract] [Full Text] [Related]
18. Termination of paroxysmal supraventricular tachycardia by tecadenoson (CVT-510), a novel A1-adenosine receptor agonist. Prystowsky EN, Niazi I, Curtis AB, Wilber DJ, Bahnson T, Ellenbogen K, Dhala A, Bloomfield DM, Gold M, Kadish A, Fogel RI, Gonzalez MD, Belardinelli L, Shreeniwas R, Wolff AA. J Am Coll Cardiol; 2003 Sep 17; 42(6):1098-102. PubMed ID: 13678937 [Abstract] [Full Text] [Related]